We describe the effect of guanidinylation of the aminoglycoside moiety on acridine-neamine-containing ligands in the stem-loop structure located at the exon 10-5'-intron junction of Tau pre-mRNA, an important regulatory element of tau gene alternative splicing. On the basis of dynamic combinatorial chemistry experiments, ligands that combine guanidinoneamine and two different acridines were synthesized and their RNA-binding properties were compared with those of their amino precursors. Fluorescence titration experiments and UV-monitored melting curves revealed that guanidinylation has a positive effect both on the binding affinity and specificity of the ligands for the stem-loop RNA, as well as on the stabilization of all RNA sequences evaluated, particularly some mutated sequences associated with the development of FTDP-17 tauopathy. However, this correlation between binding affinity and stabilization due to guanidinylation was only found in ligands containing a longer spacer between the acridine and guanidinoneamine moieties, since a shorter spacer produced the opposite effect (e.g. lower binding affinity and high destabilization). Furthermore, spectroscopic studies suggest that ligand binding does not significantly change the overall RNA structure upon binding (circular dichroism) and that the acridine moiety might intercalate near the bulged region of the stem-loop structure (UV-Vis and NMR spectroscopy).
Introduction
RNA has enormous potential as a drug target since it is involved in many essential biological processes including the regulation of transcription and translation, as well as the control of gene expression. From a medicinal chemistry point of view, the ability of RNA to adopt complex three-dimensional architectures by folding local structures (e.g. hairpins, stem-loops, bulges, etc.) provides the oportunity to generate small molecules that could selectively bind and regulate its functions.
1 Targeting such secondary structures found in miRNA precursors or in pre-mRNA, in most cases well-defined stem-loop structures, is particularly attractive since it would allow us to interfere with miRNA maturation and, for instance, to manipulate miRNA levels or to regulate alternative splicing, respectively.
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Despite the enormous potential applications of RNA as a drug target, there are few small molecules with the optimal properties, e.g. high affinity and good specificity for a given RNA sequence. 1, 3 Today, the rational design of RNA ligands continues to be a difficult task mainly due to our poor understanding of RNA recognition principles and to the high conformational dynamics of this macromolecule, which hinders the prediction of tertiary structures and, for instance, the de novo design of RNA ligands. 4 In addition, it is also important to confer RNAbinding small molecules with pharmacological properties such as cell permeability to generate drug-like molecules. 1b,5 Within this scenario, the combination of small molecules with known RNA-binding properties offers new opportunities for generating RNA ligands with an optimal balance between affinity and specificity. 6 We have recently described the usefulness of this approach in combination with dynamic combinatorial chemistry (DCC) 7 to identify ligands for the stem-loop structure located at the exon 10-5' intron junction of Tau pre-mRNA. 8 In vitro and in vivo experiments had previously demonstrated that this stem-loop structure is an important regulatory element in pre-mRNA splicing since the extent of exon 10 inclusion is inversely proportional to its stability. 9 The fact that mutations found in patients with frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) diminish the stability of this stem-loop structure, led to the search for small molecules that selectively bind and stabilize to this structure, in particular the mutated variants. 8, 10 Such compounds are expected to restore the physiological balance of Tau protein isoforms generated upon alternative splicing of the tau gene and, consequently, the tauopathy to be treated.
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In our previous work, selected compounds in DCC experiments showed some interesting properties, including high to medium binding affinities, moderate specificities and the ability to stabilize both the wt RNA and some mutated sequences. 8 The most promising RNA-3 templated ligands combined a small aminoglycoside, neamine (Nea or Nea2 in Scheme 1),
and heteroaromatic moieties such as azaquinolone or acridines (Azq, Acr1 or Acr2 in Scheme 1). We hypothesize that such molecules interact with RNA via intercalation of the planar acridine moiety, probably in the bulge of the stem-loop structure, 10c,12 as well as through electrostatic interactions and/or hydrogen bonds between the ammonium groups of the aminoglycoside and the RNA. This combination might be responsible for the stabilization ability but also for the moderate specificities of Tau acridine-neamine ligands.
On the basis of these precedents, we wondered whether guanidinylation of the amino functions in the aminoglycoside moiety of acridine-neamine ligands would allow the affinity, specificity and stabilizing properties to be positively tuned. In fact, guanidinoglycosides, 13 like naturally occurring aminoglycosides, bind RNA preferentially over DNA and, more importantly, their high binding affinity and ability to discriminate between RNA molecules is substantially improved with respect to their aminoglycoside precursors through this chemical modification. For example, binding of guanidinoneomycin B to an RNA helix from the HIV-1 frameshift site resulted in a considerable increase in the thermodynamic stability of the RNA target (the melting temperature was shifted by at least 10 o C in the presence of 2 M urea). 14 It is also important to consider that the introduction of guanidinium groups into the aminoglycoside scaffold will have a positive effect on the cell permeability of the ligands.
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Here we report the synthesis of new Tau RNA ligands that combine guanidinoneamine and acridine moieties together with several biophysical studies on their interaction with RNA. The overall results show that guanidinylation has a positive effect on the binding affinity, specificity and ability of the ligands to stabilize RNA, including the mutated sequences.
However, this effect was found to be highly dependent on the length of the spacer between both fragments since a shorter linker had a negative effect both on affinity and on stabilizing capacity.
Results and Discussion
Exploring the effect of neamine guanidinylation using Dynamic Combinatorial
Chemistry. Scheme 1 a) Sequences and secondary structure of wild-type (wt) and +3 and +14 mutated Tau stemloop RNAs. Exonic sequences are shown in capital letters and intronic sequences in lower case.
Nucleotides involved in base pairs identified previously by NMR are connected by a dash. 9a When required, biotin or fluorescein derivatization was performed at the 5' end. The ends of the chains were modified with 2'-O-methylribonucleosides (denoted by an asterisk). b) Structure and peptide sequence of the building blocks used in the DCC experiments in our previous work 8 and in the present study.
For this purpose, we planned the synthesis of a new thiol-containing monomer, NeaG4 (Scheme 2), which is the guanidinylated analogue of the neamine monomer containing the longer spacer between the aminoglycoside and the thiol group (Nea in Scheme 1). Nea was reacted with a large excess of N,N'-di-Boc-N"-triflylguanidine (20 mol eq), a powerful guanidinylating reagent usually employed in the preparation of guanidinoglycosides, 16 in the presence of dithiothreitol (5 mol eq) and triethylamine (120 mol eq) at RT under an Ar atmosphere (Scheme 2). Once the reaction reached completion (about 4 days), the Boc- non-interacting homo-and heterodimers with streptavidin anchored to magnetic beads using a magnet. The final step of the DCC experiment involved washing the beads with a hot (90ºC) acidic (0.1% TFA) aqueous solution to denature the RNA and release RNA-bound ligands, which were then identified and quantified by UV-MS-HPLC (Fig. 1 ). Comparison with the control experiment (RNA free exchange experiment) indicated the amplification of three disulphide heterodimers ( Fig. 1 ): Acr2-Nea2 (≈800%), Acr2-Nea (≈250%) and Acr2-NeaG4 (≈450%). To our surprise, a large amount of the NeaG4-SS t Bu monomer remained unaltered after 1 week of incubation. This observation reveals that the disulphide exchange with the tert-butylsulphenyl protected monomer was not efficient under the air-mediated oxidation conditions employed for carrying out the DCC experiments.
Despite the fact that a true thermodynamic equilibrium was not reached after 1 week of incubation, neither in the presence nor in the absence of RNA, two conclusions can be drawn from these results. First, as previously found, ligands incorporating the Acr2 fragment are amplified in much higher proportions than those containing other heteroaromatic moieties 7 such as Azq or Acr1. 8 This confirms the high binding affinity of Acr2-containing ligands for Tau RNA, particularly when this acridine is combined with the neamine monomer that contains the shorter spacer between the thiol group and the aminoglycoside core (e.g. Acr2-
Nea2 amplification was three-fold higher than that of Acr2-Nea). Second, despite the fact that a large amount of the NeaG4-SS t Bu monomer did not participate in the disulphide exchange reactions, the amplification of the guanidinylated analogue of Acr2-Nea, namely Acr2-NeaG4, was substantially higher, thereby suggesting a high binding affinity for wt RNA.
Hence, we can conclude from these DCC results that replacement of the amino functions by guanidinium groups in the aminoglycoside moiety in ligands containing both acridine and neamine fragments might have a positive effect on their binding affinity.
Synthesis of the guanidinylated ligands. On the basis of the DCC results, we planned the synthesis of the guanidinylated analogues of three acridine-neamine compounds previously identified as Tau RNA ligands: Acr1-Nea, Acr2-Nea and Acr2-Nea2. 8 The structures of the parent ligands as well as of their guanidinylated analogues (Acr1-NeaG4, Acr2-NeaG4 and Acr2-Nea2G4, respectively) are shown in Scheme 3. For comparison purposes, the length and the type of linkage between the aminoglycoside and the acridine moieties were the same as those of the non-guanidinylated ligands (e.g. a disulphide linkage in Acr2-Nea2G4 and the thioether isostere (CH 2 -S) in Acr1-NeaG4 and Acr2-NeaG4).
Synthesis of the Acr1-NeaG4 ligand was carried out by reaction between the thiol-containing Boc-protected guanidinoneamine and the acryloyl-derivatized acridine (Scheme 3) in the presence of a slight excess of sodium hydride (3 mol eq) for 4 h at RT under Ar. The Bocprotected guanidinylated intermediate was treated with a 1:1 mixture of TFA/DCM in the presence of TIS and EDT to afford the desired Acr1-NeaG4 ligand after reversed-phase MPLC purification (two-step yield: 20%). Acr2-NeaG4 and Acr2-Nea2G4 were prepared by direct guanidinylation of their precursors, Acr2-Nea and Acr2-Nea2G4, respectively, following the procedure used for the synthesis of (Boc) 8 NeaG4. A 40-fold mol eq excess of N,N'-di-Boc-N"-triflylguanidine in the presence of NEt 3 was used in both cases, and after acidic deprotection and HPLC purification, the desired ligands were obtained: Acr2-NeaG4
(yield: 56%) and Acr2-Nea2G4 (yield: 20%). In conclusion, both the conjugate addition of (Boc) 8 NeaG4 over the acryloyl-derivatized acridine and the direct guanidinylation of the amino-precursors allow the synthesis of guanidinoneamine-acridine ligands with moderate yields. The EC 50 values of the three guanidinoneamine-acridine ligands together with those of their amino precursors are shown in Table 1 . As a control, neamine and guanidinoneamine binding affinities for wt RNA were also determined. Consistent with our previous results, 8 guanidinylated ligands containing the Acr2 moiety showed higher binding affinities than the ligand containing Acr1 (e.g. EC 50 = 2.4 µM for Acr2-NeaG4 vs. EC 50 = 18.9 µM for Acr1-NeaG4). As expected based on the DCC results, the guanidinylation of the four amino groups of neamine had a positive effect on the binding affinity of Acr1-Nea and Acr2-Nea. Indeed, the EC 50 value for Acr1-NeaG4 was 1.5 times higher than for Acr1-Nea, and this effect was even higher (about 2.5 times) when comparing the values of Acr2-NeaG4 and Acr2-Nea. To our surprise, the EC 50 value of the guanidinylated ligand containing the shorter spacer between acridine and neamine, Acr2-Nea2G4, was higher than that of Acr2-Nea2, which
indicates that in this case guanidinylation had a negative influence on binding affinity. This effect was the opposite of that previously found with non-guanidinylated ligands, since the affinity was approximately three times higher for Acr2-Nea2 than for Acr2-Nea. As expected, the binding affinity of guanidinoneamine for wt RNA was substantially higher than that of neamine. The fact that this effect was stronger than that found in acridine-neamine ligands could be attributed to the high promiscuity of small amino-and guanidinoglycosides alone, which could have several binding sites in our RNA target. However, the effect of
guanidinylation on the binding affinity of ligands combining acridine and neamine may be strongly influenced by the existence of a preferred binding site for their non-guanidinylated precursors in the RNA target, probably driven in our case by intercalation of the heteroaromatic fragment. 8, 10, 12 The opposite effect of guanidinylation on Acr2-Nea and Acr2-Nea2 suggests that the introduction of four guanidinium groups into the ligand with the shortest spacer might generate sterical hindrance, leading to a loss of affinity. However, the longer distance between the two fragments in Acr1-NeaG4 or in Acr2-NeaG4 would not impede the optimal accommodation of acridine and guanidinoneamine in the stem-loop RNA structure, leading to an increase in affinity due to the positive effect of the guanidium groups. Table 1 . Binding of the ligands to wt RNA in the absence or in the presence of a tRNA competitor.
[a] All fluorescence measurements (0.25 µM RNA) were performed in 10 mM sodium phosphate buffer pH 6.8, 100 mM NaCl and 0.1 mM Na 2 EDTA.
[b] Measured in the presence of a 30-fold nucleotide excess of a mixture of tRNA (tRNA mix ).
Fluorescence binding assays were repeated in the presence of a large excess (30-fold nucleotide excess) of a tRNA mix from baker's yeast that contains a mixture of pre-and mature tRNAs. These competitive experiments allow the specificity of the ligands to be determined, according to the ratio between the EC 50 value in the presence of the competitor and the EC 50 value in the absence of the competitor. 18b,19 Again, the specificity of the guanidinylated ligands was shown to be highly dependent both on the nature of the acridine building block and on the distance of the spacer between the acridine and the guanidinoneamine units. In the presence of the competitor, the EC 50 values of Acr2-NeaG4 and Acr2-Nea2G4 for Tau RNA were increased by 10-fold and 14-fold, respectively, whereas that of Acr1-NeaG4 was only increased by 2.4-fold. Hence, the Acr1 moiety confers higher specificity to acridine- that shown by non-guanidinylated ligands, since Acr1-Nea was more specific for Tau RNA than Acr2-Nea/Nea2. Interestingly, guanidinylation of Acr1-Nea and Acr2-Nea2 had a positive effect on the specificity of both ligands since the specificity ratio of Acr1-NeaG4 and Acr2-Nea2G4 was reduced about 1.5-fold when compared with that of their amino precursors.
However, a similar specificity ratio was obtained for Acr2-Nea and Acr2-NeaG4. As shown in Table 1 , the specificity ratio for Acr2-Nea2G4 was higher than that of Acr2-NeaG4,
showing a similar trend to their non-guanidinylated precursors, Acr2-Nea and Acr2-Nea2.
The overall results indicate that guanidinylation of acridine-neamine ligands has a positive (Acr1-NeaG4 and Acr2-Nea2G4) or minimal (Acr2-NeaG4) effect on their specificity for Tau RNA. In addition, a longer spacer always confers higher specificity to Acr2-containing ligands, either non-guanidinylated, as previously reported (Acr2-Nea vs. Acr2-Nea2) 8 or guanidinylated (Acr2-NeaG4 vs. Acr2-Nea2G4), thus differing from the trend found in acridine-neomycin ligands with the HIV-1 RRE RNA target. 19b, 20 It is interesting that no correlation between affinity and specificity was found in guanidinylated Acr2-containing ligands, since the ligand with the highest affinity (Acr2-NeaG4) was also the most specific.
This trend contrasts with that found in their non-guanidinylated precursors, in which there was an inverse correlation between the two parameters.
Effect of the guanidinylated ligands on the thermal stability of Tau RNA targets. Our next objective was to evaluate the ability of the guanidinylated ligands to stabilize Tau RNA targets, in particular some of the mutated sequences associated with FTDP-17 development.
The thermal stability of the stem-loop structures (wt and +3 and +14 mutants) was determined by UV melting experiments by monitoring the absorbance as a function of temperature. The midpoint of the transition (see Figures S1-S3 in the Supporting Information) is referred to as the melting temperature (T m ), which is indicative of the thermal stability of the RNA secondary structure. As shown in Table 2 , ∆T m values indicate the effect of the ligands on the thermal stability of RNA upon complexation, whereas ∆T m G indicate the effect of guanidinylation compared with that of the parent non-guanidinylated ligand.
As with non guanidinylated ligands, replacement of Acr1 by Acr2 in the acridineguanidinoneamine ligands with the longest spacer caused an increase in the T m value of all
RNAs. This increase was particularly high for the +3 (∆T m = +5.9 o C with Acr2-NeaG4 vs.
∆T m = +2.9 o C with Acr1-NeaG4) and the +14 mutants (∆T m = +2.6 o C with Acr2-NeaG4 vs.
∆T m = +1.2 o C with Acr1-NeaG4). As shown in Table 2 , guanidinylation of Acr1-Nea or Acr2-Nea always had a positive effect on the thermal stability of all RNAs upon complexation with the ligands, particularly with the +3 mutant (∆T m G = +1.7 o C for Acr1-NeaG4 and ∆T m G = +3.1 o C for Acr2-NeaG4). The fact that no significant additional stabilization was provided by guanidinoneamine compared to neamine suggests that both aminoglycosides might interact with Tau RNA through the major groove or with the loop.
However, the interaction of the heteroaromatic moiety of the acridine-guanidinoneamine ligands within the duplex of the stem-loop structure (see below) through an intercalative or stacking mechanism might be responsible for the optimal allocation of the guanidinoneamine fragment, thereby causing significant changes in RNA T m values. To our surprise, the T m values of all RNAs were clearly decreased (e.g. ∆T m G = -2.8 o C with the +3 mutant, see Table   2 ) in the presence of the guanidinylated ligand with the shortest spacer, Acr2-Nea2G4. In some cases, the ability of this ligand to stabilize wt RNA or the mutant sequences was even lower than that of the non-guanidinylated ligands with the longest spacer, Acr1-Nea or Acr2-Nea.
Taken together, these results show a good correlation between binding affinities of the properties. Since the optimal molecular arrangement of a ligand can also be dramatically perturbed by guanidinylation, it is important to carefully select the amino groups to be guanidinylated since otherwise this chemical modification could negatively affect RNAbinding properties. Spectroscopic studies of the complexes formed between Tau RNA and the guanidinylated ligands. The overall results indicate that guanidinylated ligands with the longest spacer between the acridine moieties and neamine, Acr1-NeaG4 and Acr2-NeaG4,
showed an adequate balance between affinity, specificity and RNA stabilizing properties.
Hence, we wanted to gain some insight into the effect of this chemical modification on the structure of the RNA-ligand complexes in comparison with that of their non-guanidinylated precursors, Acr1-Nea and Acr2-Nea. 8 First, Acr1-NeaG4 and Acr2-NeaG4 were titrated with increasing quantities of wt Tau RNA to determine whether the acridine moiety has an active role in the interaction with RNA.
Consistent with our previous results with non-guanidinylated ligands, strong hypochromism (30-40%) was observed in the UV-Vis spectra of both ligands in the first stage of the titration
∆T m G [b] No ligand 66. increasing amounts of wt RNA (0-2 eq) in a 10 mM sodium phosphate buffer, pH 6.8, containing 100 mM NaCl and 0.1 mM Na 2 EDTA.
NMR spectroscopy was used to gain an insight into the effect of guanidinylation on the binding mode of acridine-neamine containing ligands. The effect of ligand addition on the imino region of the NMR spectra of wt RNA was studied using Acr1-Nea and Acr1-NeaG4.
As shown in Fig. S4 and U+2) may be a consequence of strong binding of the guanidinoglycoside moiety of Acr1-NeaG4 in comparison with that of neamine in Acr1-Nea.
Finally, circular dichroism was used to study the conformation of the RNA-ligand complexes.
CD spectra of wt and of the +3 mutant were recorded in the presence of 1 mol eq of the most representative guanidinylated ligands, Acr1-NeaG4 and Acr2-NeaG4. As shown in Fig. 4 , the typical spectra of A-form RNA were obtained for wt and +3 sequences alone, with a strong negative band at 211 nm, two small bands at 223 and 234 nm, and a strong positive band at 268 nm; the presence of a shoulder at 280 nm is a characteristic feature of duplexes capped with a loop structure. 22 Upon binding of Acr1-NeaG4 or Acr2-NeaG4, the CD spectra of the complexes were essentially superimposable on that of wt RNA (Fig. 4A ) which indicates that the conformation of the stem-loop structure had not been substantially altered. However, the effect of the ligands on the conformation of the +3 mutated RNA was more substantial possibly due to the intrinsically lower thermodynamic stability compared with that of wt. As shown in Fig. 4B , the alterations induced by the ligands in duplex CD bands included a decrease in the intensity of the positive band at 234 nm and a concomitant increase in the ellipticity of the positive band at 268 nm, together with a small wavelength shift (a 3 nm blueshift for Acr1-Nea/NeaG4 and a 1 nm red-shift for Acr2-Nea/NeaG4). The overall changes are also consistent with a small binding-induced change in the conformation of the +3 mutant sequence, although typical A-spectra were maintained in all cases, this being important for the recognition of the ligand-stabilized stem-loop by the splicing regulatory machinery. It is particularly interesting to note that ligands with higher binding affinities and stabilizing
properties (e.g. Acr2-NeaG4) induced higher alterations in the CD spectra of RNA upon binding. 
Conclusions
In summary, we have shown that guanidinylation of the aminoglycoside moiety of ligands combining neamine and acridine strongly influences their RNA-binding properties (affinity, specificity and stabilizing ability). The distance between the two fragments in our modularly assembled ligands is a key parameter since it influences the effect of guanidinylation on these properties, either positively or negatively. For example, guanidinylation has a positive effect on acridine-neamine ligands containing the longest spacer since higher binding affinities for Tau RNA were determined by fluorimetry (e.g. EC 50 = 2.4 µM for Acr2-NeaG4 vs. EC 50 = 5.9 µM for Acr2-Nea). However, guanidinylation of the analogous ligand containing the shortest spacer resulted in a reduced binding affinity for Tau RNA (e.g. EC 50 = 3.6 µM for Acr2-Nea2G4 vs. EC 50 = 2.1 µM for Acr2-Nea2). The same correlation was observed in the ability of such ligands to stabilize Tau RNA, particularly the +3 and +14 mutated sequences associated with the development of FTDP-17. For example, Acr2-NeaG4 stabilized the +3 mutant by 5.9 ºC whereas Acr2-Nea2G4 only increased the T m value by 2.9 ºC. Hence, guanidinium modification in ligands with the longest spacer substantially increased the stability of the target RNA (+3.1ºC) whereas the guanidinium-containing derivative with the shortest spacer showed less thermal stabilization (-2.8ºC) than the parent non-guanidinylated ligand. These results might be attributed to the generation of some sterical hindrance by the four guanidinium groups when acridine and guanidinoneamine are closely attached, which may make it difficult for both entities of the ligand to adopt the optimal binding site in RNA.
In addition, competition studies performed in the presence of an excess of tRNA revealed that guanidinylation of the aminoglycoside fragment in Tau acridine-neamine ligands has, in general, a positive effect on their specificity. Furthermore, CD spectroscopy indicated that guanidinylated ligands do not significantly change the overall structure of the stem-loop RNA, whereas UV-Vis and NMR spectroscopy titration experiments suggested that the heteroaromatic moiety intercalates or stacks, probably near the bulging adenine of the stemloop structure.
It is also important to mention that there was a correlation between the RNA-binding RNase-free reagents, solutions and materials were used when manipulating deprotected oligoribonucleotides. RNase-free water was obtained directly from a Milli-Q system equipped with a 5000-Da ultrafiltration cartridge.
Solid-phase syntheses were performed manually in a polypropylene syringe fitted with a polyethylene disc (building blocks and peptides), or using the ABI3400 automatic DNA synthesizer from Applied Biosystems (oligonucleotides).
Thin-layer chromatography analyses (TLC) were conducted on aluminium plates coated with a 0.2 mm thick layer of silica gel 60 F 254 (Merck). Purification by flash column chromatography was carried out using silica gel 60 (230-400 mesh).
Reversed-phase high-performance liquid chromatography (HPLC) analyses were carried out on Kromasil or Nucleosil C 18 columns (250x4.6 mm, 10 or 5 µm, flow rate: 1 mL/min), using linear gradients of 0.045% TFA in H 2 O and 0.036% TFA in ACN for peptides, monomers and ligands, and 0.1 M aqueous NH 4 HCO 3 , and a 1:1 mixture of 0.1 M aqueous NH 4 HCO 3 and ACN for RNA. In some cases, purification was carried out using the same analytical column.
A [Vydac C 18 ]-filled glass column (22x2 cm, 15-20 µm, 300 Å) was used for medium pressure liquid chromatography (MPLC), using aqueous and ACN solutions containing 0.05% TFA (flow rate: 2-3 mL/min). Elution was carried out by connecting a piston pump to the mixing chamber of a gradient-forming device and to the top of the glass column. The mixing chamber of the gradient-forming device was the flask containing solvent A, which was connected through a stopcock to the flask containing solvent B. The bottom of the preparative column was connected to an automatic fraction collector through a UV/Vis detector which was also connected to a chart recorder using the appropriate ports. Equilibration of the column was carried out with 200 mL of solvent A, and 600 mL of each mobile phase was introduced in the appropriate compartments of the gradient-forming device.
NMR spectra were recorded at 25ºC on Varian spectrometers (400 or 500 MHz) using deuterated solvents. Tetramethylsilane (TMS) was used as an internal reference (0 ppm) for 1 H spectra recorded in CDCl 3 and the residual signal of the solvent (77.16 ppm) for 13 General procedure for the RNA-templated DCC experiments. DCC experiments were carried out as previously described. 8 Briefly, 6 nmol of biotinylated wt RNA were annealed in 240 µL of buffer (50 mM Tris-HCl, pH 7.7, 100 mM NaCl and 0.1 mM Na 2 EDTA) by heating to 90 ºC for 5 min and then slowly cooling to room temperature. After overnight incubation at RT, the solutions were stored at 4 ºC. Then, annealed biotinylated RNA was added to an Eppendorf tube containing the quantified (Ellman's test) thiol building blocks, and the resulting mixture left to stand at RT under air without stirring. At the desired time, the disulfide exchange was stopped by the addition of 45-70 µL of 0.1 % TFA solution in water (final pH ∼ 5-6).
The biotinylated RNA and the binding ligands were isolated with streptavidin-coated magnetic beads (Biomag Streptavidin, 5 mg mL -1 suspension, Qiagen). A magnet was used in all washing procedures to retain the beads in the tube while the supernatant was pipetted off.
First, the beads (500 µL of suspension for each DCL aliquot) were separated from the commercial buffer solution and washed with an acidic buffer (3 x 500 µL of 50 mM Tris-HCl, pH 5.8, 100 mM NaCl and 0.1 mM Na 2 EDTA). DCL aliquots were added to the washed beads and incubated at room temperature. After 20 min, the beads were retained in the vessel using the magnet and the supernatant solution was pipetted off again. Then, the beads were treated to remove the non-interacting ligands and building blocks (3 x 200 µL of 50 mM TrisHCl, pH 5.8, 100 mM NaCl and 0.1 mM Na 2 EDTA). Finally, the beads were washed with a hot solution of 0.1% TFA in H 2 O in order to liberate RNA-binding ligands (3 x 200 µL, incubation at 90 ºC for 10 min). The solutions were combined and evaporated in a Speed-Vac.
The final residue was dissolved in 0.1 % TFA in H 2 O and analysed by UV-MS HPLC.
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Elution was performed on a GraceSmart C 18 column (150 x 2.1 mm, 5 µm, flow rate: 0.25 mL min -1 ) with linear gradients of H 2 O and ACN containing both solvents either 0.1% formic acid or 0.1 % formic acid and 0.01 % TFA to avoid the overlapping of some peaks and to allow a more accurate integration. All peak areas of the HPLC traces were integrated and normalized taking into account the extinction coefficient of each compound at the detection wavelength (260 nm). 164.7, 164.5, 164.4, 164.3, 158.3, 158.0, 157.6, 157.6, 154.7, 154.5, 154.2, 154.0, 98.0, 87.7, 84.8, 84.8, 84.7, 84.6, 80.6, 80.6, 80.6, 80.5, 78.4, 77.0, 74.9, 73.4, 73.0, 71.9, 55.4, 52.2, 50.3, 44.3, 35.5, 35.4, 31.2, 29.4, 28.8-28.3, 26.8, 24.9 a TFA/DCM mixture (2 mL, 1:1) containing 2.5 % of TIS, and the mixture was stirred at RT for 2 h. Then, the solution was diluted with toluene (3 mL) and evaporated in vacuo. The residue was dissolved in Milli-Q H 2 O (10 mL) and the aqueous phase was washed with DCM (2 x 10 mL), diethyl ether (10 mL) and lyophilized to provide a white solid. 3, 168.4, 149.6, 143.8, 132.3, 132.0, 129.6, 128.3, 126.8, 126.6, 123.7, 38.7, 38.2, 30.3 Acr2-NeaG4: 1,3-di-Boc-2-(trifluoromethylsulfonyl)guanidine (38 mg, 96 µmol) and Acr2-Nea ligand 8 (3.4 mg, 2.4 µmol) were dissolved in a 5:3 mixture of MeOH/CHCl 3 (1 mL).
After addition of triethylamine (80 µL, 576 µmol), the reaction mixture was stirred for 4 days at RT under Ar. The mixture was concentrated in vacuo and the residue was dissolved in DCM (10 mL) and washed with a 0.1 M aqueous solution of citric acid (2 x 10 mL) and with brine (10 mL). The organic phase was taken up and dried over anhydrous MgSO 4 , filtered and concentrated in vacuo to dryness. Then, the crude was dissolved in a 1:1 mixture of TFA/DCM (1 mL) containing 2.5 % TIS. After stirring at RT for 2 h under Ar, the mixture was diluted with toluene (2 mL) and evaporated in vacuo. After two co-evaporations from toluene, the residue was dissolved in Milli-Q H 2 O (10 mL) and the aqueous phase was washed with DCM (2 x 10 mL), diethyl ether (10 mL) and lyophilized. Experimental errors were less than or equal to ± 25% of each value.
For competitive experiments, a tRNA from baker's yeast (S. cerevisiae) was purchased from
Sigma. Stock solutions of tRNA mix were quantified using an average extinction coefficient of 9.640 cm -1 per base. 19b The fluorescence binding assays were carried out as described above with the exception that a 30-fold excess (base) of the tRNA mix was added to the refolded fluoresceine-labelled RNA (or to the buffer for the titration without target RNA).
F. NMR Spectroscopy of RNA-ligand complexes. NMR spectra were acquired in a Bruker
Advance spectrometer operating at 600 MHz and equipped with a cryoprobe. Samples of the complexes were prepared by mixing the appropriate amounts of RNA and ligand and performing an annealing protocol consisting of heating to 90ºC for 3 min, followed by snap cooling on ice for 20 min. Samples were dissolved in a 10 mM sodium phosphate, pH 6.8, in a 9:1 H 2 O/D 2 O mixture and NMR spectra were recorded at 5ºC to reduce the exchange with water. Water suppression was achieved by using an excitation sculpting sequence (zgesgp).
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